PERCEPTIVE ADVISORS LLC - 09 Mar 2026 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director, 10%+ Owner
Signature
/s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
Issuer symbol
SLDB
Transactions as of
09 Mar 2026
Net transactions value
$0
Form type
4
Filing time
11 Mar 2026, 16:00:03 UTC
Previous filing
02 Jan 2026
SEC
View on sec.gov

Reporting Owners (3)

Name Relationship Address Signature Signature date CIK
PERCEPTIVE ADVISORS LLC Director, 10%+ Owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK /s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member 11 Mar 2026 0001224962
EDELMAN JOSEPH Director, 10%+ Owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK /s/ Joseph Edelman - for Perceptive Life Sciences Master Fund Ltd., By: Perceptive Advisors LLC, its investment manager, By: Joseph Edelman, its managing member 11 Mar 2026 0001164426
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Director, 10%+ Owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK /s/ Joseph Edelman 11 Mar 2026 0001249675

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Pre-Funded Warrant (right to buy) Award +8,912,655 $5.61* 8,912,655 09 Mar 2026 Common Stock 8,912,655 $0.001000 See footnote F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The terms of the Pre-Funded Warrants provide that such warrants may not be exercised if, after such exercise, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 9.99% of the shares of Common Stock then issued and outstanding after giving effect to such exercise (the "Beneficial Ownership Limitation"). As of the date hereof, the Beneficial Ownership Limitation does not permit the Master Fund (as defined herein) to exercise any of its Warrants.
F2 The Pre-Funded Warrants do not expire.
F3 The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor.
F4 Each of Mr. Edelman, the Advisor, and the Master Fund disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.